One BioMed scores $5 mln Series A

Singapore-based One BioMed Pte Ltd, a medical diagnostics company, has raised $5 million in Series A financing round. Biopath Ventures and ARCH Venture Partners led the round with participation from SEEDS Capital.

10 July 2019•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail